Fedex Corp (FDX) 171.60 $FDX Research and Markets: North

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Fedex Corp (FDX) 171.60 $FDX

Research and Markets: North America Pharmaceutical Logistics Market 2015-2019 With CEVA Logistics, DB Schenker, FedEx, Kuehne and Nagel & United Parcel Service of America Dominating
Business Wire - Wed Jul 29, 4:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/h7cz3g/pharmaceutical) has announced the addition of the "Pharmaceutical Logistics Market in North America 2015-2019" report to their offering.
FDX: 171.60 (+2.17)

North America Pharmaceutical Logistics Market 2015-2019 with CEVA Logistics, DB Schenker, FedEx, Kuehne and Nagel & United Parcel Service of America Dominating
M2 - Wed Jul 29, 4:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7jvq59/pharmaceutical) has announced the addition of the "Pharmaceutical Logistics Market in North America 2015-2019" report to their offering. The pharmaceutical logistic market in North America to grow at a CAGR of 8.38% in terms of revenue over the period 2014-2019 This report covers the present scenario and the growth prospects of the pharmaceutical logistics market in North America for the period 2015-2019. To calculate the market size, it considers revenue generated by third party logistics service providers. Pharmaceutical logistics vendors in North America have found new opportunities in the biological drugs market, which can increase their revenue and market share. The biological drug market is growing due to increased usage of biological drugs for the treatment of many chronic diseases. Many patients are now choosing biological drugs as they cause fewer side effects and are also effective in the treatment of diseases such as cancer, diabetes, rheumatoid arthritis, growth disorders, and infections such as hepatitis A, hepatitis B, and other viral infections. Biological drugs provide considerable growth opportunities to vendors because of the increasing demand for biopharmaceuticals. As a result, vendors in the market are investing heavily in R&D to develop novel biological components to treat different diseases. According to the report, the demand for the outsourcing of logistics activities to global and local vendors has increased over the years. Vendors in North America are outsourcing their logistics functions and activities to logistics companies to cut costs and increase margins. Many companies in North America manage some of their logistics supply chain functions in-house. However, logistics functions such as customs clearance and transportation are being outsourced to other parties because of the difficulties maintaining trucks and achieving optimum levels of resource utilization. Hence, transportation management in North America provides huge scope for logistics providers. Further, the report states that one of the major challenges faced by the pharmaceutical logistics market in North America is the growing regulatory pressures and tougher standards imposed by governments. Key Vendors - CEVA Logistics - DB Schenker - FedEx - Kuehne and Nagel - United Parcel Service of America Other Prominent Vendors - Agility - Air Canada Cargo - Cold Chain Technologies - CSafe Global - L&M Transportation Services - LifeConEx - Marken - Nordic Cold Storage - Sofrigam - TNT Express - UTi Transport Solutions - VersaCold - World Courier Management For more information visit http://www.researchandmarkets.com/research/7j...maceutical
FDX: 171.60 (+2.17)

Look for Shares of FedEx to Potentially Pullback after Yesterday's 2.85% Rise
Comtex SmarTrend(R) - Tue Jul 28, 4:59PM CDT
FedEx (NYSE:FDX) traded in a range yesterday that spanned from a low of $166.19 to a high of $169.65. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high of $168.89 on volume of 1.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
FDX: 171.60 (+2.17)

FedEx Set to Possibly Pullback After Yesterday's Rally of 2.85%
Comtex SmarTrend(R) - Tue Jul 28, 4:59PM CDT
FedEx (NYSE:FDX) traded in a range yesterday that spanned from a low of $166.19 to a high of $169.65. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high of $168.89 on volume of 1.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
FDX: 171.60 (+2.17)

United Parcel Service (UPS) Tops Q2 Earnings, Sales Slip - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 28, 1:29PM CDT
United Parcel Service (UPS) reported better-than-expected earnings in the quarter.
FDX: 171.60 (+2.17), RLGT: 6.81 (unch), DCIX: 2.00 (+0.01), UPS: 100.73 (+0.79)

UPS Shares Gap Up On Delivery Of Q2 Earnings Beat
at Investor's Business Daily - Tue Jul 28, 9:55AM CDT
UPS (UPS) shares are delivering Tuesday morning after the shipping company reported better-than-expected second-quarter earnings and said it expects to hit the higher end of its full-year guidance. Shares rose 3.8% to 98.73 in the stock market today....
FDX: 171.60 (+2.17), UPS: 100.73 (+0.79)

China Express Delivery Industry Report 2015
PR Newswire Europe - Tue Jul 28, 6:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4tjmtt/china_express [http://www.researchandmarkets.com/research/4tjmtt/china_express]) has announced the addition of the "China Express Delivery Industry Report, 2015" [http://www.researchandmarkets.com/research/4tjmtt/china_express] report to their offering.
FDX: 171.60 (+2.17)

Boeing 767 Past Its Prime? Just Don't Tell United Airlines or FedEx
at The Street - Tue Jul 28, 5:46AM CDT
Boeing's 767 was thought to be an aircraft at the end of its civilian life, but now United is upgrading its fleet and FedEx is buying more.
FDX: 171.60 (+2.17), BA: 144.16 (+2.35), UAL: 57.30 (-1.12)

OMVS Finding Strong Market Potential for Shared Economy Courier Service
Business Wire - Tue Jul 28, 4:00AM CDT
Market research conducted by On the Move Systems (OMVS) shows that a shared economy courier service offers clear and distinct advantages over companies built on more traditional business models. These findings bolster and strengthen OMVS's proposed service, for which the company is now actively scouting possible locations.
FDX: 171.60 (+2.17)

Boeing's Best Buddy Buys More 767s
Rich Smith, The Motley Fool - Motley Fool - Mon Jul 27, 2:00PM CDT
Step on it! FedEx delivers another multibillion-dollar order to Boeing. Photo: Boeing . On a week in which Boeing news was dominated by Boeing's earnings news , the aerospace giant didn't let that little even get in the way of getting on...
FDX: 171.60 (+2.17), BA: 144.16 (+2.35)

Stock Market News for July 24, 2015 - Market News
Zacks Equity Research - Zacks Investment Research - Fri Jul 24, 9:10AM CDT
Benchmarks ended in the red for the third-straight session on Thursday as dismal earnings results offset encouraging initial claims number
FDX: 171.60 (+2.17), MMM: 151.16 (+0.05), NSC: 85.36 (+0.44), AXP: 75.69 (+0.58), QCOM: 63.23 (+0.13), GM: 31.71 (+0.39), CAT: 77.08 (-0.70), CSX: 31.38 (+0.30), ALK: 73.90 (-0.42), SNDK: 60.21 (-0.87), UNP: 97.15 (+0.53)

FedEx and 3 Air Freight and Logistics Stocks to Buy Now
at The Street - Thu Jul 23, 7:45AM CDT
The logistics and transportation industry is growing and there are plenty of stocks within the industry expected to take flight. Here's four to buy now.
FDX: 171.60 (+2.17), CHRW: 69.84 (+3.11), EXPD: 46.64 (+1.33), BA: 144.16 (+2.35), UPS: 100.73 (+0.79)

After Yesterday's Decline of 1.23%, FedEx Offers Investors Better Value
Comtex SmarTrend(R) - Wed Jul 22, 4:31PM CDT
FedEx (NYSE:FDX) traded in a range yesterday that spanned from a low of $167.59 to a high of $171.00. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $169.32 on volume of 1.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
FDX: 171.60 (+2.17)

Watch for FedEx to Potentially Rebound After Falling 1.23% Yesterday
Comtex SmarTrend(R) - Wed Jul 22, 4:30PM CDT
FedEx (NYSE:FDX) traded in a range yesterday that spanned from a low of $167.59 to a high of $171.00. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $169.32 on volume of 1.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
FDX: 171.60 (+2.17)

Boeing Earnings Top, Outlook Cut On Tanker Charge
at Investor's Business Daily - Wed Jul 22, 10:31AM CDT
Boeing (BA) reported second-quarter earnings and revenue above Wall Street estimates Wednesday, but lowered its full-year outlook on a previously announced charge. The aerospace giant's core earnings, which exclude pension and other costs, fell 33%...
FDX: 171.60 (+2.17), BEAV: 48.11 (-0.15), BA: 144.16 (+2.35)

More Than $2.3 Million in Conservation Grants Announced by Five Star and Urban Waters Restoration Program
GlobeNewswire - Wed Jul 22, 9:14AM CDT
The National Fish and Wildlife Foundation (NFWF) today announced that 64 community-led wetland, stream and coastal restoration projects across the nation have been awarded more than $2.3 million in grants. In addition, the grantees have committed an additional $4.8 million in local project support, creating a total investment of more than $7 million in projects that will restore wildlife habitat and urban waters and will engage thousands of volunteers, students and local residents in community-based environmental stewardship projects.
FDX: 171.60 (+2.17), SO: 43.34 (-0.20)

FedEx Mulling Extra Freighters: What Does It Mean for Boeing?
Adam Levine-Weinberg, The Motley Fool - Motley Fool - Wed Jul 22, 8:05AM CDT
Package delivery giant FedEx is thinking about buying about 25 extra 767 Freighters from Boeing , according to multiple reports last week. This isn't as big a potential order as what Leeham News and Comment suggested earlier this month, when...
FDX: 171.60 (+2.17), BA: 144.16 (+2.35)

FedEx to Send 150 Drivers to National Truck Driving Championships
Business Wire - Wed Jul 22, 8:00AM CDT
150 drivers from 48 states representing FedEx Corp. (NYSE: FDX) operating companies will compete in the National Truck Driving Championships (NTDC) in St. Louis, Missouri, August 11-15.
FDX: 171.60 (+2.17)

FedEx Express Plans to Acquire 50 Additional Boeing 767-300F Aircraft
Business Wire - Tue Jul 21, 4:33PM CDT
FedEx Express, a wholly owned subsidiary of FedEx Corp. (NYSE: FDX), today agreed to purchase 50 additional 767-300F aircraft from The Boeing Company as it continues to modernize its aircraft fleet to more effectively serve its customers. In addition to the 50 confirmed orders, FedEx also has options to purchase a total of 50 767F aircraft.
FDX: 171.60 (+2.17)

Red Rock Reaches Agreement with FedEx Express to Provide Biofuels for Renewable, Low-Carbon Jet Fuel
Business Wire - Tue Jul 21, 7:00AM CDT
Red Rock Biofuels LLC, a pioneer in renewable biofuels, announced today that it will produce approximately three million gallons of low-carbon, renewable jet fuel per year for FedEx Express, a subsidiary of FedEx Corp. (NYSE:FDX). The agreement runs through 2024, with first delivery expected in 2017. FedEx joins Southwest Airlines in purchasing Red Rock's total available volume of jet fuel.
FDX: 171.60 (+2.17), LUV: 35.56 (-0.50)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 262

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 135

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 314

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 187

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 255

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 63

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 129

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 287

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 62

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading

Top 5 Most Recently Viewed Articles

Elis Announces Share Buyback Operations Details and Impact

Updated Category News Views 257

Elis Announces Share Buyback Operations Recent Trading Disclosure by Elis In alignment with European regulations governing share buybacks, Elis has disclosed transactions for the purchase of its own shares. These operations occurred from September 15 to September 19, 2025, as part of an authorized buyback program approved by the General Shareholders' Meeting earlier in...

Continue Reading
One Stop Systems Set To Showcase Innovations at ROTH Event

Updated Category News Views 122

One Stop Systems Announces Participation in Major Conference One Stop Systems, Inc. (OSS), renowned for its cutting-edge solutions in rugged Enterprise Class computing, is gearing up to engage with investors at a prominent industry event. This year, OSS will be present at the 37th Annual ROTH Conference, scheduled for mid-March. The event will serve as a platform for the...

Continue Reading
Solid Biosciences to Engage at BioPharma Symposium Soon

Updated Category News Views 80

Solid Biosciences to Participate at BioPharma Symposium Solid Biosciences Inc. (NASDAQ: SLDB), a pioneering life sciences company, is excited to announce a significant upcoming event where they will showcase their advancements in the field of precision genetic medicine. The company's Chief Medical Officer, Dr. Gabriel Brooks, is scheduled to participate in a Genetic...

Continue Reading
JD Vance Confronted by Protesters While Out with Daughter

Updated Category News Views 378

Intense Encounter for Vice President JD Vance Recently, Vice President JD Vance found himself in a challenging situation when he was confronted by a group of pro-Ukraine protesters while spending time with his daughter. This encounter, which took place in Ohio, captured not only the essence of political tensions but also brought forth the complexities of personal moments...

Continue Reading
Exciting Addition to MyCardiologist as Dr. Koshy Joins Team

Updated Category News Views 325

New Addition to MyCardiologist Enhances Cardiovascular Care MyCardiologist, a leading name in advanced cardiovascular care, proudly announces the joining of Dr. Linda Koshy to their reputable medical team. Dr. Koshy is a skilled general and interventional cardiologist known for her exceptional ability to manage intricate coronary artery disease as well as endovascular...

Continue Reading